Use access key #2 to skip to page content.
$3.25 -0.10 (-2.99%)
10/7/2008 3:45 PM

Nektar Therapeutics (NKTR)

CAPS Rating:
**

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.

View All Commentary (NKTR)

Recs

2

Avatar honcharella (86.93) Submitted: 3/14/07 7:22 PM : Underperform Start Price: $11.91 NKTR Score: 44.52

This company just can't make a move upward. One of many with this type of technology and also one of many that just fails to produce results in the form of profits. Maybe one day... Just not today.

Report this Post Replies: 0 | Reply

Featured Broker Partners